Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression
出版年份 2016 全文链接
标题
Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression
作者
关键词
HMGB1, Gliomas, Brain tumors, RAGE, TLRs, Immunotherapy
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 94, Issue 8, Pages 867-874
出版商
Springer Nature
发表日期
2016-06-05
DOI
10.1007/s00109-016-1435-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis
- (2016) Wei Lv et al. CANCER LETTERS
- High-mobility group Box 1: A novel inducer of the epithelial–mesenchymal transition in colorectal carcinoma
- (2015) Lingyin Zhu et al. CANCER LETTERS
- High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity
- (2015) M. Chen et al. CANCER RESEARCH
- MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation
- (2015) Yu Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Unknown
- (2015) Huan Yang et al. MOLECULAR MEDICINE
- Glioblastoma multiforme: Pathogenesis and treatment
- (2015) Constantinos Alifieris et al. PHARMACOLOGY & THERAPEUTICS
- mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1
- (2015) Jing Luo et al. MEDICAL SCIENCE MONITOR
- Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation
- (2015) Jennifer R. Molina et al. NEOPLASIA
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA, through NF-κB mediated activation of MMP-9
- (2014) Young Dae Lee et al. BMB Reports
- The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines
- (2014) Ruo-Chan Chen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Unknown
- (2014) Daolin Tang et al. MOLECULAR MEDICINE
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma
- (2014) Qingbing Meng et al. TUMOR BIOLOGY
- Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma
- (2014) Shuanglin Deng et al. Protein & Cell
- Effects of Single or Combined Treatments with Radiation and Chemotherapy on Survival and Danger Signals Expression in Glioblastoma Cell Lines
- (2014) Francesca Pasi et al. Biomed Research International
- HMGB1 in Cancer: Good, Bad, or Both?
- (2013) R. Kang et al. CLINICAL CANCER RESEARCH
- Growth inhibitory effects of three miR-129 family members on gastric cancer
- (2013) Xiuchong Yu et al. GENE
- Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells
- (2013) Raquel Ordoñez et al. JOURNAL OF PINEAL RESEARCH
- RAGE and TLRs: Relatives, friends or neighbours?
- (2013) Zaridatul Aini Ibrahim et al. MOLECULAR IMMUNOLOGY
- Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion
- (2013) K. Vinnakota et al. NEURO-ONCOLOGY
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection
- (2013) H. Yanai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
- (2013) M Karaayvaz et al. Cell Death & Disease
- β-defensin-3 negatively regulates TLR4–HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells
- (2012) Piyushi Gupta et al. CELLULAR SIGNALLING
- S100P-Derived RAGE Antagonistic Peptide Reduces Tumor Growth and Metastasis
- (2012) T. Arumugam et al. CLINICAL CANCER RESEARCH
- HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
- (2012) Clarissa A. Wild et al. ORAL ONCOLOGY
- Molecular mechanisms of necrosis in glioblastoma: The role of glutamate excitotoxicity
- (2010) Evan Noch et al. CANCER BIOLOGY & THERAPY
- The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
- (2009) R Kang et al. CELL DEATH AND DIFFERENTIATION
- Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity
- (2009) M. Candolfi et al. CLINICAL CANCER RESEARCH
- Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
- (2009) Hye Chung et al. Journal of Translational Medicine
- HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
- (2009) James F Curtin et al. PLOS MEDICINE
- Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies
- (2008) Andreas A. Argyriou et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
- (2008) Barry I. Hudson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now